Antioxidant treatment of therapy-resistant idiopathic membranous nephropathy with probucol: A pilot study

Wiener Klinische Wochenschrift

Volumn 114, Issue 4, 2002, Pages 143-147

  Haas, Martin ^a   Mayer, Gert ^a   Wirnsberger, Gerhard ^a   Holzer, Herwig ^a   Ratschek, Manfred ^a   Neyer, Ullrich ^a   Neuweiler, Josef ^a   Kramar, Reinhard ^a   Schneider, Brigitte ^a   Breiteneder Geleff, Silvana ^a   Regele, Heinrich M ^a   Hörl, Walter H ^a   Kerjaschki, Dontscho ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Antioxidants; Glomerulonephritis; Membranous nephropathy; Proteinuria

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; MEVINOLIN; PROBUCOL;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; HEYMANN NEPHRITIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIPID PEROXIDATION; MALE; MEMBRANOUS GLOMERULONEPHRITIS; MULTICENTER STUDY; PROTEINURIA; QT INTERVAL; REMISSION; SIDE EFFECT;

ADULT; ANTICHOLESTEREMIC AGENTS; ANTIOXIDANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; KIDNEY FUNCTION TESTS; LIPID PEROXIDATION; LOVASTATIN; MALE; MIDDLE AGED; PROBUCOL; PROSPECTIVE STUDIES; PROTEINURIA; TREATMENT OUTCOME;

EID: 0037186750     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Membranous glomerulonephritis
2. Prognosis of untreated patients with membranous nephropathy
3. A 10 year follow up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy
4. A review of therapeutic studies of idiopathic membranous nephropathy
5. Prednisolone and chlorambucil therapy for idiopathic membranous nephropathy with progressive renal failure
6. Management of idiopathic membranous nephropathy: Evidence - Based recommendations
7. Treatment of progressive membranous nephropathy. A randomized trial comparing cyclophosphamide and corticosteroids with steroids alone
8. Treatment of idiopathic membranous nephropathy: The dilemma of who, when, and how
9. Probucol associated tachyarrhythmic events and QT prolongation: Importance of gender
10. Antibodies to glycolipids activate complement and promote proteinuria in passive Heymann nephritis
11. Proteinuria in passive Heymann nephritis is associated with lipid peroxidation and formation of adducts on type IV collagen
12. Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules?
13. Probucol inhibits oxidative modification of low density lipoprotein
14. Effect of probucol dosage on plasma lipid and lipoprotein levels and on protection of low density lipoprotein against in vitro oxidation in humans
15. Conventional treatment of idiopathic nephrotic syndrome and membranous nephropathy in adults
16. Predicting chronic renal insufficiency in idiopathic membranous glomerulonephritis
17. Use of mycophenolate mofetil in resistant membranous nephropathy
18. Effectiveness of steroid therapy in different stages of membranous nephropathy
19. Treatment of the hyperlipidemia of the nephrotic syndrome: A controlled trial
20. Decrease of urine protein after treatment with probucol in patients with mild glomerulonephritis and atherosclerosis